Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Examen

LEHNE’S PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSES AND PHYSICIAN ASSISTANTS 2ND EDITION ROSENTHAL TEST BANK

Puntuación
-
Vendido
-
Páginas
479
Grado
A+
Subido en
26-03-2025
Escrito en
2024/2025

LEHNE’S PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSES AND PHYSICIAN ASSISTANTS 2ND EDITION ROSENTHAL TEST BANK 1. An APRN works in a urology clinic under the supervision of a physician who does not restrict the types of medications the APRN is allowed to prescribe. State law does not require the APRN to practice under physician supervision. How would the APRN‘s prescriptive authority be described? a. Full authority b. Independent c. Without limitation d. Limited authority ANS: B The APRN has independent prescriptive authority because the regulating body does not require that the APRN work under physician supervision. Full prescriptive authority gives the provider the right to prescribe independently and without limitation. Limited authority places restrictions on the types of drugs that can be prescribed.DIF: Cognitive Level: ComprehensionREF: p. 1TOP: Nursing Process: I MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 2. Which factors increase the need for APRNs to have full prescriptive authority? a. More patients will have access to health care. b. Enrollment in medical schools is predicted to decrease. c. Physician‘s assistants are being utilized less often. d. APRN education is more complex than education for physicians. ANS: A Implementation of the Affordable Care Act has increased the number of individuals with health care coverage, and thus the number who have access to health care services. The increase in the number ofpatients creates the need for more providers with prescriptive authority. APRNs can fill this practice gap.DIF: Cognitive Level: ComprehensionREF: p. 2TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 3. Which factors could be attributed to limited prescriptive authority for APRNs? Select all that apply. a. Inaccessibility of patient care b. Higher health care costs c. Higher quality medical treatment d. Improved collaborative care e. Enhanced health literacy ANS: A , B Limiting prescriptive authority for APRNs can create barriers to quality, affordable, and accessible patient care. It may also lead to poor collaboration among providers and higher health care costs. It would not directly impact patient‘s health literacy.DIF: Cognitive Level: ComprehensionREF: p. 2TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 4. Which aspects support the APRN‘s provision for full prescriptive authority? Select all that apply. a. Clinical education includes prescription of medications and disease processes. b. Federal regulations support the provision of full authority for APRNs. c. National examinations provide validation of the APRN‘s ability to provide safecare. d. Licensure ensures compliance with health care and safety standards. e. Limiting provision can decrease health care affordability. ANS: A , C , D APRNs are educated to practice and prescribe independently without supervision. National examinations validate the ability to provide safe and competent care. Licensure ensures compliance with standards to promote public health and safety. Limited prescriptive authority creates numerous barriers to quality, affordable, and accessible patient care.DIF: Cognitive Level: ComprehensionREF: pp. 1-2TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 5. Which aspects support the APRN‘s provision for full prescriptive authority? Select all that apply. a. Clinical education includes prescription of medications and disease processes. b. Federal regulations support the provision of full authority for APRNs. c. National examinations provide validation of the APRN‘s ability to provide safecare. d. Licensure ensures compliance with health care and safety standards. ANS: A , C , D APRNs are educated to practice and prescribe independently without supervision. National examinations validate the ability to provide safe and competent care. Licensure ensures compliance with standards to promote public health and safety. Limited prescriptive authority creates numerous barriers to quality, affordable, and accessible patient care.DIF: Cognitive Level

Mostrar más Leer menos
Institución
LEHNE’S PHARMACOTHERAPEUTICS
Grado
LEHNE’S PHARMACOTHERAPEUTICS

Vista previa del contenido

? 012345678 677156373521743753132
4

514
325 74!"
@ABCADEFGHIJKILMNHOJIGOPNQLRFSMJFITUIVLOTFGJILNQLOFVPJRORFIVTF
GHWRQLQIVFIRRQRNIVNRFXVTFOTQNQMVFJMROVNHI@FNORNFYIVZF
F
F
L[\]^_`FabFG`_cd`e]^ef_FIg^[h`e^iF
N_c^FY\jkF
Kgl^e]l_FL[hed_F
F
mn& op?oqrs?tuvwx?yp?z?{vu|u}~?|ypy?{p€v?‚ƒ?x{„vyxyup?u†?z?„ƒ~xyyzp?tƒu?€ux?pu‚?vx‚vy‚?
‚ƒ?‚~„x?u†?‡€yz‚yupx?‚ƒ?oqrs?yx?z||ut€?‚u?„vxvyˆn?‰‚z‚?|zt?€ux?pu‚?vŠ{yv?‚ƒ?
oqrs?‚u?„vz‚y?{p€v?„ƒ~xyyzp?x{„vyxyupn?‹ut?tu{|€?ŒŽ‘’“”•?„vxvy„‚y?z{‚ƒuvy‚~?
ˆ?€xvyˆ€–?
?
zn&—{||?z{‚ƒuvy‚~?
ˆn&˜p€„p€p‚?
n&™y‚ƒu{‚?|y‡y‚z‚yup?
€n&šy‡y‚€?z{‚ƒuvy‚~?
?
os‰›?œ?
ƒ?oqrs?ƒzx?yp€„p€p‚?„vxvy„‚y?z{‚ƒuvy‚~?ˆz{x?‚ƒ?v}{|z‚yp}?ˆu€~?€ux?pu‚?vŠ{yv?
‚ƒz‚?‚ƒ?oqrs?tuvw?{p€v?„ƒ~xyyzp?x{„vyxyupn?—{||?„vxvy„‚y?z{‚ƒuvy‚~?}yx?‚ƒ?„vuy€v?
‚ƒ?vy}ƒ‚?‚u?„vxvyˆ?yp€„p€p‚|~?zp€?ty‚ƒu{‚?|y‡y‚z‚yupn?šy‡y‚€?z{‚ƒuvy‚~?„|zx?vx‚vy‚yupx?
up?‚ƒ?‚~„x?u†?€v{}x?‚ƒz‚?zp?ˆ?„vxvyˆ€nž˜—›?Ÿu}py‚y?š|›?Ÿu‡„vƒpxyupr —›?„n?m¡q›?
s{vxyp}?qvuxx›?˜?¢‰Ÿ›?sŸš £?Ÿ|yp‚?s€x?Ÿz‚}uv~›?qƒ~xyu|u}y?˜p‚}vy‚~›?qƒzv‡zu|u}y?
zp€?qzvp‚vz|?ƒvz„yx?
?
?
¤n& ™ƒyƒ?†z‚uvx?ypvzx?‚ƒ?p€?†uv?oqrsx?‚u?ƒz?†{||?„vxvy„‚y?z{‚ƒuvy‚~–?
zn&¢uv?„z‚yp‚x?ty||?ƒz?zxx?‚u?ƒz|‚ƒ?zvn?
ˆn& pvu||‡p‚?yp?‡€yz|?xƒuu|x?yx?„v€y‚€?‚u?€vzxn?
n&‘¥•¦§¦¨©”•?zxxyx‚zp‚x?zv?ˆyp}?{‚y|yª€?|xx?u†‚pn?
€n&oqrs?€{z‚yup?yx?‡uv?u‡„|«?‚ƒzp?€{z‚yup?†uv?„ƒ~xyyzpxn?
os‰›?o?
˜‡„|‡p‚z‚yup?u†?‚ƒ?o††uv€zˆ|?Ÿzv?o‚?ƒzx?ypvzx€?‚ƒ?p{‡ˆv?u†?yp€yy€{z|x?ty‚ƒ?ƒz|‚ƒ?
zv?uvz}¬?zp€?‚ƒ{x?‚ƒ?p{‡ˆv?tƒu?ƒz?zxx?‚u?ƒz|‚ƒ?zv?xvyxn?ƒ?ypvzx?yp?‚ƒ?
p{‡ˆv?u†„z‚yp‚x?vz‚x?‚ƒ?p€?†uv?‡uv?„vuy€vx?ty‚ƒ?„vxvy„‚y?z{‚ƒuvy‚~n?oqrsx?zp?†y||?
‚ƒyx?„vz‚y?}z„nž˜—›?Ÿu}py‚y?š|›?Ÿu‡„vƒpxyupr —›?„n?¤¡q›?s{vxyp}?qvuxx›?
˜‡„|‡p‚z‚yup?¢‰Ÿ›?sŸš £?Ÿ|yp‚?s€x?Ÿz‚}uv~›?qƒ~xyu|u}y?˜p‚}vy‚~›?qƒzv‡zu|u}y?zp€?
qzvp‚vz|?ƒvz„yx?
?
?
­n& ™ƒyƒ?†z‚uvx?u{|€?ˆ?z‚‚vyˆ{‚€?‚u?|y‡y‚€?„vxvy„‚y?z{‚ƒuvy‚~?†uv?oqrsx–?
‰|‚?z||?‚ƒz‚?z„„|~n?


? #$%&'($)*+*&,-.&/0+((+112332&4&/0+((+1123325-)0$$6/$7&
#89:;8,<:8$'&$=&:089&*$/<7+':&89&8((+>)(&

,? 012345678 677156373521743753132
4

514
325 74!"
?
?
@A&BC@DDEFFGHGIGJK?LM?N@JGECJ?D@OE?
HA&PGQREO?RE@IJR?D@OE?DLFJF?
DA&PGQREO?ST@IGJK?UEVGD@I?JOE@JUECJ?
VA&BUNOLWEV?DLII@HLO@JGWE?D@OE?
EA&XCR@CDEV?RE@IJR?IGJEO@DK?
YZ[\?Y?]?^?
_GUGJGCQ?NOEFDOGNJGWE?@TJRLOGJK?MLO?Y`aZF?D@C?DOE@JE?H@OOGEOF?JL?ST@IGJK]?@MMLOV@HIE]?@CV?@DDEFFGHIE?
N@JGECJ?D@OEA?BJ?U@K?@IFL?IE@V?JL?NLLO?DLII@HLO@JGLC?@ULCQ?NOLWGVEOF?@CV?RGQREO?RE@IJR?D@OE?DLFJFA?
bcdefghidjfcdiklmnchodkpqrncdqrckmjcstdumrhcudhkcmlrnovwbxy?zLQCGJGWE?_EWEI\?zLUNOERECFGLCaX{\?
NA?|}~`\?ZTOFGCQ?`OLDEFF\?BUNIEUECJ@JGLC?[z\?Zz_X€?zIGECJ?ZEEVF?z@JEQLOK\?`RKFGLILQGD?
BCJEQOGJK\?`R@OU@DLILQGD?@CV?`@OECJEO@I?}REO@NGEF?
?
?
A& ‚RGDR?@FNEDJF?FTNNLOJ?JRE?ƒ„ †st?NOLWGFGLC?MLO?MTII?NOEFDOGNJGWE?@TJRLOGJK‡?
[EIEDJ?@II?JR@J?@NNIKA?
?
@A&zIGCGD@I?EVTD@JGLC?GCDITVEF?NOEFDOGNJGLC?LM?UEVGD@JGLCF?@CV?VGFE@FE?NOLDEFFEFA?
HA&{EVEO@I?OEQTI@JGLCF?FTNNLOJ?JRE?NOLWGFGLC?LM?MTII?@TJRLOGJK?MLO?Y`aZFA?
DA&Z@JGLC@I?Eˆ@UGC@JGLCF?NOLWGVE?W@IGV@JGLC?LM?JRE?ƒ„ †st?@HGIGJK?JL?NOLWGVE?F@MED@OEA?
VA&_GDECFTOE?ECFTOEF?DLUNIG@CDE?‰GJR?RE@IJR?D@OE?@CV?F@MEJK?FJ@CV@OVFA?
EA&_GUGJGCQ?NOLWGFGLC?D@C?VEDOE@FE?RE@IJR?D@OE?@MMLOV@HGIGJKA?
?
YZ[\?Y?]?z?]?Š?
Y`aZF?@OE?EVTD@JEV?JL?NO@DJGDE?@CV?NOEFDOGHE?GCVENECVECJIK?‰GJRLTJ?FTNEOWGFGLCA?Z@JGLC@I?
Eˆ@UGC@JGLCF?W@IGV@JE?JRE?@HGIGJK?JL?NOLWGVE?F@ME?@CV?DLUNEJECJ?D@OEA?_GDECFTOE?ECFTOEF?
DLUNIG@CDE?‰GJR?FJ@CV@OVF?JL?NOLULJE?NTHIGD?RE@IJR?@CV?F@MEJKA?_GUGJEV?NOEFDOGNJGWE?@TJRLOGJK?
DOE@JEF?CTUEOLTF?H@OOGEOF?JL?ST@IGJK]?@MMLOV@HIE]?@CV?@DDEFFGHIE?N@JGECJ?D@OEAŠB{\?zLQCGJGWE?_EWEI\?
zLUNOERECFGLCaX{\?NNA?‹Œ|}~`\?ZTOFGCQ?`OLDEFF\?BUNIEUECJ@JGLC?[z\?Zz_X€?zIGECJ?ZEEVF?
z@JEQLOK\?`RKFGLILQGD?BCJEQOGJK\?`R@OU@DLILQGD?@CV?`@OECJEO@I?}REO@NGEF?
?
A& ‚RGDR?@FNEDJF?FTNNLOJ?JRE?ƒ„ †st?NOLWGFGLC?MLO?MTII?NOEFDOGNJGWE?@TJRLOGJK‡?
[EIEDJ?@II?JR@J?@NNIKA?
?
@A&zIGCGD@I?EVTD@JGLC?GCDITVEF?NOEFDOGNJGLC?LM?UEVGD@JGLCF?@CV?VGFE@FE?NOLDEFFEFA?
HA&{EVEO@I?OEQTI@JGLCF?FTNNLOJ?JRE?NOLWGFGLC?LM?MTII?@TJRLOGJK?MLO?Y`aZFA?
DA&Z@JGLC@I?Eˆ@UGC@JGLCF?NOLWGVE?W@IGV@JGLC?LM?JRE?ƒ„ †st?@HGIGJK?JL?NOLWGVE?F@MED@OEA?
VA&_GDECFTOE?ECFTOEF?DLUNIG@CDE?‰GJR?RE@IJR?D@OE?@CV?F@MEJK?FJ@CV@OVFA?
YZ[\?Y?]?z?]?Š?
Y`aZF?@OE?EVTD@JEV?JL?NO@DJGDE?@CV?NOEFDOGHE?GCVENECVECJIK?‰GJRLTJ?FTNEOWGFGLCA?Z@JGLC@I?
Eˆ@UGC@JGLCF?W@IGV@JE?JRE?@HGIGJK?JL?NOLWGVE?F@ME?@CV?DLUNEJECJ?D@OEA?_GDECFTOE?ECFTOEF?
DLUNIG@CDE?‰GJR?FJ@CV@OVF?JL?NOLULJE?NTHIGD?RE@IJR?@CV?F@MEJKA?_GUGJEV?NOEFDOGNJGWE?@TJRLOGJK?
DOE@JEF?CTUEOLTF?H@OOGEOF?JL?ST@IGJK]?@MMLOV@HIE]?@CV?@DDEFFGHIE?N@JGECJ?D@OEAŠB{\?zLQCGJGWE?_EWEI\?



? #$%&'($)*+*&,-.&/0+((+112332&4&/0+((+1123325-)0$$6/$7&
#89:;8,<:8$'&$=&:089&*$/<7+':&89&8((+>)(&

,? 012345678 677156373521743753132
4

514
325 74!"
?
@ABCDEFEGHIAGJKLM?CCN?OPQRSTM?UVDHIGW?TDAXEHHM?YBCZEBEG[\[IAG? ]^@M?U@_K`?@ZIEG[?
UEEaH?@\[EWADbM?TFbHIAZAWIX?YG[EWDI[bM?TF\DB\XAZAWIX?\Ga?T\DEG[ED\Z?RFED\CIEH?
?
cN& d?e\BIZb?GVDHE?CD\X[I[IAGED?CD\X[IXIGW?IG?]\IGE?IH?FIDEa?\[?\?CD\X[IXE?\XDAHH?H[\[E?ZIGEH?IG?
fIDWIGI\N?gFIXF?\HCEX[?Ae?CD\X[IXE?B\b?XF\GWE?eAD?[FE?dTJUh?
\N&RFE?dTJU?iIZZ?F\jE?ZEHH?CDEHXDIC[IjE?\V[FADI[b?IG?[FE?GEi?CAHI[IAGN?
kN&RFE?dTJU?iIZZ?F\jE?BADE?CDEHXDIC[IjE?\V[FADI[b?IG?[FE?GEi?CAHI[IAGN?
XN&RFE?dTJU?iIZZ?F\jE?ElV\Z?CDEHXDIC[IjE?\V[FADI[b?IG?[FE?GEiCAHI[IAGN?
aN&RFE?mnopqr?\V[FADI[b?iIZZ?aECEGa?AG?eEaED\ZDEWVZ\[IAGHN?
?
dU^M?d?
fIDWIGI\?\ZZAiH?ZIBI[Ea?CDEHXDIC[IjE?\V[FADI[bs?iFIZE?]\IGE?WIjEH?eVZZ?\V[FADI[b?[A?XED[IeIEa?GVDHE?
CD\X[I[IAGEDHN?RFE?eEaED\Z?WAjEDGBEG[?aAEH?GA[?DEWVZ\[E?CDEHXDIC[IjE?\V[FADI[bNtYLM?@AWGI[IjE?
_EjEZM?@ABCDEFEGHIAGJKLM?CN?uRSTM?UVDHIGW?TDAXEHHM?YBCZEBEG[\[IAG?]^@M?U@_K`?@ZIEG[?
UEEaH?@\[EWADbM?TFbHIAZAWIX?YG[EWDI[bM?TF\DB\XAZAWIX?\Ga?T\DEG[ED\Z?RFED\CIEH?
?
vwxyz{|}~€y|zy‚x€ƒ|}„ }†w{|y„}‡yˆ{‰†x€Šw„€‹Œ}z†yŒ€ƒ„}†{‰†y€ƒ„w‰Œy„xŽ€zŒ€Œ‘€
’|}‡{y„€€v}{‰wz}~€“„ˆ”€•y~y†{‰wz€}zŒ€ƒ„yx†„‰‡{‰wz€–„‰{‰z”€
—yx{€˜}z™€
šˆ~{‰‡~y€’|w‰†y€
€
›N& œAi?X\G?XAZZ\kAD\[IAG?iI[F?\?CF\DB\XIH[?IBCDAjE?CAHI[IjE?AV[XABEH?eAD?C\[IEG[Hh?
^EZEX[?\ZZ?[F\[?\CCZbN?
?
\N&TF\DB\XIH[H?X\G?HVWWEH[?eAAaH?[F\[?iIZZ?FEZC?iI[F?[FE?žŸ¡¢Ÿqr?XAGaI[IAGN?
kN&TF\DB\XIH[H?F\jE?\aaI[IAG\Z?IGeADB\[IAG?AG?aDVW?IG[ED\X[IAGHN?
XN&RFE?CF\DB\XIH[?X\G?HVWWEH[?\aElV\[E?BEaIX\[IAG?aAHIGWN?
aN&TF\DB\XIH[H?F\jE?eIDH[F\Ga?£GAiZEaWE?Ae?[FE?e\XIZI[b?eADBVZ\DbN?
EN&TF\DB\Xb?X\G?\Z[ED?CDEHXDIC[IAGH?iFEG?GEXEHH\Db?[A?CDEjEG[?C\[IEG[?F\DBN?
?
dU^M?¤?s?@?s?t?
TDAjIaEDH?HFAVZa?XAZZ\kAD\[E?iI[F?CF\DB\XIH[H?kEX\VHE?[FEb?iIZZ?ZI£EZb?F\jE?\aaI[IAG\Z?IGeADB\[IAG?
AG?eADBVZ\Dbs?aDVW?IG[ED\X[IAGHs?\Ga?HVWWEH[IAGH?eAD?\aElV\[E?BEaIX\[IAG?aAHIGWN?tIE[I[I\GH?X\G?
¥ž¦¡§¨©©ªr§«¡¬©¥¥¡¢ªžŸ©¢r§Ÿ©§Ÿ«¡žŸ§Ÿ­¡§žŸ¡¢Ÿqr§¬©¢ªŸ©¢®§¯­¡§­ž«¥ž¬rŸ§¬ž¢§¬©¢Ÿž¬Ÿ§Ÿ­¡§
CDEHXDIkED?\kAV[?lVEH[IAG\kZE?CDEHXDIC[IAGHs?kV[?X\GGA[?\Z[ED?[FE?CDEHXDIC[IAG?iI[FAV[?GA[IeIX\[IAG?
Ae?\Ga?\CCDAj\Z?kb?[FE?CDAjIaEDNtYLM?@AWGI[IjE?_EjEZM?@ABCDEFEGHIAGJKLM?CN?°RSTM?UVDHIGW?
TDAXEHHM?tI\WGAHIH?]^@M?U@_K`?@ZIEG[?UEEaH?@\[EWADbM?TFbHIAZAWIX?YG[EWDI[bM?JEaVX[IAG?Ae?
JIH£?TA[EG[I\Z?




? #$%&'($)*+*&,-.&/0+((+112332&4&/0+((+1123325-)0$$6/$7&
#89:;8,<:8$'&$=&:089&*$/<7+':&89&8((+>)(&

, ? 012345678 677156373521743753132
4

514
325 74!"
?
@A& BCDEFGHE?CIGJGHEJ?KFEL?MGNFIFOP?EIGPGHJ?IGQOFIFHR?BEFSDH?DMPFHFJEIDEFTHA?ULG?CITSFMGI?TVWDIG?
FJ?HTE?FH?ELG?VDWFNFEXA?YLFWL?DWEFTH?ZX?ELG?HOIJG?FJ?PTJE?DCCITCIFDEG[?
?
DA&\ZEDFH?D?EGNGCLTHG?TIMGIA?
ZA&]THEDWE?ELG?TH^WDNN?LTJCFEDNFJEA?
WA&\ZEDFH?DH?TIMGI?VITP?ELG?WLDIRG?HOIJGA?
MA&YDFE?VTI?D?KIFEEGH?BEFSDH?TIMGIA?
?
B_`a?B?
bH?DH?GPGIRGHWX?JFEODEFTHc?JOWL?DJ?MGNFIFOP?EIGPGHJ?KFEL?JGFdOIG?DWEFSFEXc?FE?FJ?DWWGCEDZNG?ET?CITSFMG?
D?EGNGCLTHG?TIMGIA?]THEDWEFHR?ELG?TH^WDNN?LTJCFEDNFJE?TI?KDFEFHR?VTI?D?KIFEEGH?TIMGI?KTONM?EDeG?PTIG?
EFPG?ELDH?DSDFNDZNG?VTI?D?CDEFGHE?KFEL?LFRL?JGFdOIG?IFJeA?YIFEFHR?DH?TIMGI?FJ?TOEJFMG?ELG?JWTCG?TV?
CIDWEFWG?VTI?ELG?WLDIRG?HOIJGAfbga?]TRHFEFSG?hGSGNa?BCCNFWDEFTHijga?CA?kU\la?_OIJFHR?lITWGJJa?
bPCNGPGHEDEFTH?m`]a?_]hjn?]NFGHE?_GGMJ?]DEGRTIXa?lLXJFTNTRFW?bHEGRIFEXa?iGMOWEFTH?TV?iFJe?
lTEGHEFDN?
?
?
oA& B?CDEFGHE?KFEL?WLITHFW?CDFH?WDNNJ?ELG?pqrstuvqwx?TVVFWG?ET?IGQOGJE?D?IGVFNN?TH?ELGFI?TyXWTHEFHA?
YLFWL?DWEFTH?FJ?PTJE?DCCITCIFDEG[?
?
DA&gDy?DH?TIMGI?ET?ELG?CLDIPDWXA?
ZA&`WLGMONG?DH?DCCTFHEPGHE?KFEL?ELG?CDEFGHEA?
WA&zGIFVX?ELG?p{|tv}|wx?DMLGIGHWG?ET?MIOR?IGRFPGHA?
MA&fGEGIPFHG?ELG?p{|tv}|wx?WOIIGHE?PGMFWDEFTH?MTJDRGA?
B_`a??~?
`WLGMONG?bb?PGMFWDEFTHJ?DIG?HTE?GNFRFZNG?VTI?IGVFNNJc?DHM?CIGJWIFCEFTHJ?POJE?ZG?LDHMKIFEEGHA?bE?FJ?
tprq|{}|€|r€svqt‚€|ƒv€p{|tv}|wx€{uƒvqv}„v€|r€|ƒv€uq†?IGRFPGH?DHM?MGEGIPFHG?ELG?WOIIGHE?MTJDRG?
TV?PGMFWDEFTH‡?LTKGSGIc?ELFJ?WDH?ZG?DWWTPCNFJLGM?ZX?JWLGMONFHR?DH?DCCTFHEPGHE?DHM?GSDNODEFHR?
ELG?CDEFGHE?FH?CGIJTHAfbga?]TRHFEFSG?hGSGNa?BCCNFWDEFTHijga?CA?@U\la?_OIJFHR?lITWGJJa?
bPCNGPGHEDEFTH?m`]a?_]hjn?]NFGHE?_GGMJ?]DEGRTIXa?lLXJFTNTRFW?bHEGRIFEXa?iGMOWEFTH?TV?iFJe?
lTEGHEFDN?
?
?
ˆ‰A&BCDEFGHE?CIGJWIFZGM?DPTyFWFNNFH?VTI?JEIGCETWTWWDNCLDIXHRFEFJ?IGCTIEJ?HGK?THJGE?TVD?VNDEc?FEWLX?
IGM?IDJL?TH?ELG?WLGJE?DHM?HGWeA?YLFWL?DWEFTH?FJ?PTJE?FPCTIEDHE[?
?
DA&lITSFMG?D?MFVVGIGHE?CIGJWIFCEFTHA?
ZA&fFJWTHEFHOG?ELG?PGMFWDEFTHA?
WA&lIGJWIFZG?DH?DHEFLFJEDPFHG?WIGDPA?
MA&BJJGJJ?VTI?IGJCFIDETIX?WTPCITPFJGA?
?
B_`a?~?
Šƒv€pqtrqt|‚€{„|tr}€tx€|r€utx„r}|t}v€|ƒv€vut„{|tr}€|r€pqvsv}|€‹rqxv}t}†€r€|ƒv€p{|tv}|wx€
JXPCETPJA?B?MFVVGIGHE?CIGJWIFCEFTH?KTONM?ZG?CITSFMGMc?ETCFWDN?DHEFLFJEDPFHG?PDX?ZG?DMPFHFJEGIGMc?
DHM?ELG?CDEFGHE?KTONM?ZG?DJJGJJGM?VTI?IGJCFIDETIX?FHSTNSGPGHEc?ZOE?ELGJG?DWEFTHJ?KTONM?HTE?ZG?



? #$%&'($)*+*&,-.&/0+((+112332&4&/0+((+1123325-)0$$6/$7&
#89:;8,<:8$'&$=&:089&*$/<7+':&89&8((+>)(&

Escuela, estudio y materia

Institución
LEHNE’S PHARMACOTHERAPEUTICS
Grado
LEHNE’S PHARMACOTHERAPEUTICS

Información del documento

Subido en
26 de marzo de 2025
Número de páginas
479
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

  • prescriptive authority
$10.49
Accede al documento completo:

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Conoce al vendedor
Seller avatar
NurseZoe
1.0
(1)

Conoce al vendedor

Seller avatar
NurseZoe Academia-hub
Ver perfil
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
2
Miembro desde
1 año
Número de seguidores
0
Documentos
76
Última venta
10 meses hace

1.0

1 reseñas

5
0
4
0
3
0
2
0
1
1

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes